It is well established that patients with moderate to severe acute COVID-19 have elevated autoantibodies against type I IFNs (24), but our data suggest that autoantibodies against MDA5 upstream of type I IFN production may be involved in the pathogenesis of PASC. This evidence concerns the gene IFIH1 and long COVID-19.